Neurological biomarkers market growing expeditiously high demand of noninvasive diagnostic for Alzheimer Diseases

October 14, 2021

Neurological Biomarkers

Developing cost-effective and reliable blood-based neurological biomarkers that can aid in detecting the onset of disease before excessive damage occurs

Rise in number of research activities focused towards developing efficient biomarkers that can aid in early diagnosis of Alzheimer's and Parkinson's diseases is expected to drive the market growth”
— Allied Market Research
PORTLAND, OR, UNITED STATES, October 14, 2021 / -- Introduction of affordable biomarker testing, growing demand for non-invasive diagnostic techniques, and increasing adoption in clinical trials drive the growth of the market. However, strict government regulations and ethical concerns regarding early diagnosis restrict the market growth. On the other hand, increased demand for personalized medicines would create new opportunities for the market.

Neurological Biomarkers Market for Alzheimer's and Parkinson's Diseases - Global Opportunity Analysis and Industry Forecast, 2018-2025. The report presents detailed analyses of the key market trends, drivers & opportunities, market size & forecasts, top investment pockets, and competitive landscape. According to the report, the neurological biomarkers market for Alzheimer's and Parkinson's disease was valued at $3.95 billion in 2017, and is expected to reach $8.57 billion by 2025, registering a CAGR of 10.1% from 2018 to 2025.

Explore Report Description@

U.S. neurological Alzheimer's disease biomarkers market to contribute highest revenue by 2025

The neurological Alzheimer's disease biomarkers market in the U.S. contributed more than one-third of the global market revenue in in 2017, owing to significant increase in the number of educational institutes and rise in research & development activities. Asia-Pacific would grow at the fastest CAGR of 12.7% from 2018 to 2025, owing to rise in geriatric population who are suffer from Alzheimer's disease in countries such as India and Japan.

China neurological Parkinson's disease biomarkers market to grow the fastest through 2025

The neurological Parkinson's disease biomarkers market in China would grow at the fastest CAGR of 10.1% from 2018 to 2025 due to the rise in the number of individuals diagnosed with Parkinson's disease and implementation of pharmacological treatment and surgical intervention procedures. However, the U.S. contributed more than one-third of the total market share in 2017, owing to rise in prevalence of Parkinson's disease among geriatric population in the region.

For Purchase Enquiry:

Frontrunners in the industry

The leading market players analyzed in the report include Abbott Laboratories, Proteome Sciences, Myriad RBM, Athena Diagnostics, Thermo Fisher Scientific, Quanterix Corporation, Immunarray Pvt. Ltd., Psynova Neurotech, Diagenic ASA, and Bio-Rad Laboratories. These market players have adopted strategies such as partnerships, collaborations, expansions, joint ventures, and others to strengthen their position in the industry.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial:

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Vascular Imaging Market Global Research By 2030

Wound Debridement Market Global Research By 2030

RNA Sequencing Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
email us here
+18007925285 ext.
Visit us on social media: